Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis

12 Jul 2005

Abstract excerpt

Multiple sclerosis (MS) is a complex disease that seems to depend on several pathophysiological processes. Because of its varied clinical presentation, natural history, and response to therapeutic interventions, MS can be considered to be a group of diseases that have not been yet characterized, thus resulting in difficult evaluation of prognosis. In the last few years, the role of autoAbs in MS has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16014416
DOI: 10.1073/pnas.0503178102

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosisPMID 16014416Read ↗

Anti-Glycan Antibodies as Biomarkers for Diagnosis and PrognosisSemantic proximity Read ↗

Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteinsSemantic proximity Read ↗

Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.Semantic proximity Read ↗

Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptidesSemantic proximity Read ↗

Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.Semantic proximity Read ↗

Distortion of the Self-Reactive IgG Antibody Repertoire in Multiple Sclerosis as a New Diagnostic ToolSemantic proximity Read ↗

Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosisSemantic proximity Read ↗

Structural insights into the antigenicity of myelin oligodendrocyte glycoproteinSemantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating DiseasesSemantic proximity Read ↗

New antigenic candidates in multiple sclerosis: Identification by serological proteome analysisSemantic proximity Read ↗

The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's diseaseSemantic proximity Read ↗

The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.